title: PROVE-IT to IMPROVE-IT: Why LDL-C Goals Still Matter in Post-ACS Patients.
authors.affiliation: Division of Cardiology, Mayo Clinic, Rochester, Minnesota. Electronic address: wright.scott@mayo.edu.
authors.forename: R Scott
authors.initials: RS
authors.lastname: Wright
authors.affiliation: Division of Cardiology, Mayo Clinic, Rochester, Minnesota; Section of Scientific Publication, Mayo Clinic, Rochester, Minnesota.
authors.forename: Joseph
authors.initials: J
authors.lastname: Murphy
mesh_terms: D054058:Acute Coronary Syndrome / Q000188:drug therapy*; D000069438:Ezetimibe / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008297:Male; D009203:Myocardial Infarction / Q000517:prevention & control*; D019821:Simvastatin / Q000008:administration & dosage*
chemical_list: D019821:Simvastatin; D000069438:Ezetimibe
keywords: acute coronary syndrome; ezetimibe; lipid modifying therapy; secondary prevention